Simplex Trading
EIGR

Simplex Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Simplex Trading’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-117
Closed -$2K – 10169
2023
Q2 		$2K Sell
117
-40
-25% -$1.23K ﹤0.01% 8524
2023
Q1 		$4K Sell
157
-30
-16% -$1.4K ﹤0.01% 8245
2022
Q4 		$6K Buy
187
+150
+405% +$18K ﹤0.01% 8002
2022
Q3 		$8K Sell
37
-76
-67% -$18.7K ﹤0.01% 8470
2022
Q2 		$21K Sell
113
-1,297
-92% -$261K ﹤0.01% 7578
2022
Q1 		$351K Buy
1,410
+1,390
+6,950% +$220K ﹤0.01% 4323
2021
Q4 		$3K Sell
20
-1,107
-98% -$214K ﹤0.01% 9907
2021
Q3 		$294K Hold
1,127
– – ﹤0.01% 4936
2021
Q2 		$287K Buy
1,127
+1,114
+8,569% +$278K ﹤0.01% 5055
2021
Q1 		$346K Buy
13
+8
+160% +$2.52K ﹤0.01% 3952
2020
Q4 		$200K Buy
+5
New +$1.43K ﹤0.01% 4604
2020
Q3 		– Hold
0
– – – 7241
2020
Q1 		– Hold
0
– -$7K – 8457
2019
Q4 		– Hold
0
– – – 6587
2015
Q2 		– Hold
0
– -$94K – 6007
2015
Q1 		– Hold
0
– – – 1135

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Simplex Trading's EIGR Position: Q1 2024 in Review

Simplex Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 437 shares — an estimated $2K sold.

Simplex Trading first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $532K in Q1 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Simplex Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 437 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $2K.
  • Simplex Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 13 quarters.
  • Simplex Trading's Eiger BioPharmaceuticals, Inc. position peaked at $532K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.